Research Article Open Access

Use of a Caprine Serum Fraction-Immunomodulator to Reduce Mortality in Commercial and Large-Bodied Turkey Lines Infected with Pasteurella multocida

Authors

CORRESPONDING AUTHOR
E.D. Peebles
Department of Poultry Science, Mississippi State University, Mississippi State, Mississippi, 39762, USA
|
K.O. Willeford
Department of Biochemistry and Molecular Biology, Mississippi State University, Mississippi State, Mississippi, 39762, USA
|
R.W. Keirs
College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, 39762, USA
|
K.E. Nestor
Department of Animal Sciences, Ohio State University, Wooster, Ohio, 44691, USA
|
Y.M. Saif
Department of Animal Sciences, Ohio State University, Wooster, Ohio, 44691, USA
|
C. Wang
College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, 39762, USA
|
C.J. Matyi
Department of Biochemistry and Molecular Biology, Mississippi State University, Mississippi State, Mississippi, 39762, USA
|
J.W. Anderson
Department of Animal Sciences, Ohio State University, Wooster, Ohio, 44691, USA
|
M.T. Kidd
Department of Poultry Science, Mississippi State University, Mississippi State, Mississippi, 39762, USA
|
R. Pulikanti
Department of Poultry Science, Mississippi State University, Mississippi State, Mississippi, 39762, USA
DOI 10.3923/ijps.2008.818.824
PDF

Abstract

The effectiveness of an injected caprine serum fraction-immunomodulator (CSF-I2) as an immunostimulant in male and female F-line and commercial turkey poults infected with fowl cholera (Pasteurella multocida) was examined in separate trials. In the first 2 of 3 controlled trials, the effects of an i.m. injection of CSF-I2 given 24 h prior to a P. multocida challenge, administered by s.c. injection, on mortality and days to death in F-line turkeys was determined. The CSF-I2 reduced mortality but did not affect average number of days to death of F-line turkeys across trials and sexes when administered 24h prior to a P. multocida challenge. In the third trial, the effects of an i.m. injection of CSF-I2 given to a commercial line of turkeys 24h prior to an s.c. injection of P. multocida on mortality and days to death were determined. While positive control commercial turkey poults experienced an 85% level of mortality across sex, the administration of CSF-I2 did not significantly reduce percentage mortality or average number of days to death. The difference in the effects of CSF-I2 on mortality in F-line and commercial turkey poults challenged with P. multocida suggests that CSF-I2 did not impart immunostimulation to commercial turkeys as it did in F-line turkeys that were infected with P. multocida. Therefore, genetic variation in turkeys may be an important consideration before using CSF-I2 as an immunomodulator to protect juvenile turkeys against fowl cholera.

Keywords:

Caprine serum, caprine serum fraction-immunomodulator, mortality, Pasteurella multocida, Turkeys

Article Metrics

215 Abstract Views
117 File Views
0 Downloads

Article Citation Metrics

How to Cite

Peebles, E., Willeford, K., Keirs, R., Nestor, K., Saif, Y., Wang, C., Matyi, C., Anderson, J., Kidd, M., & Pulikanti, R. (2008). Use of a Caprine Serum Fraction-Immunomodulator to Reduce Mortality in Commercial and Large-Bodied Turkey Lines Infected with Pasteurella multocida. International Journal of Poultry Science, 7(8), 818–824. https://doi.org/10.3923/ijps.2008.818.824

Most read articles by the same author(s)

1 2 > >>